SetPoint Medical Expands RA Neuroimmune Therapy Access
Atlantic City, New Jersey, U.S., September 28, 2026 SetPoint Medical has announced an important clinical-access milestone following the completion...
Neurosurgery
Advertisement
UCB Wins FDA Breakthrough Therapy Designation for CIMZIA
Brussels, Belgium, September 9, 2026 UCB announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy...
CraniUS Wins FDA 510(k) Clearance for Cranial Implant
Baltimore, Maryland, September 9, 2026 CraniUS Therapeutics has received U.S. Food and Drug Administration (FDA) 510(k) clearance for the...
Insightec Reaches 10,000 EMEA Patients With MRgFUS
HAIFA, Israel and FRANKFURT, Germany — September 8, 2026 Insightec announced that more than 10,000 patients across Europe, the...
Hyperfine Expands Clinical Evidence for Swoop Portable MRI
GUILFORD, Conn., July 30, 2026 Hyperfine, Inc. announced the publication of multiple peer-reviewed clinical studies highlighting the expanding role...
Advertisements
MMI Advances REMIND Alzheimer’s Study After FDA IDE Approval
JACKSONVILLE, Fla., July 30, 2026 Medical Microinstruments (MMI) announced that the U.S. Food and Drug Administration (FDA) has approved...
Synergy Spine Accelerates Cervical Disc Adoption Across the U.S.
LOUISVILLE, Colo., July 21, 2026 Synergy Spine Solutions has announced a major commercial milestone for its FDA-approved Synergy Disc®,...
Saluda Medical Receives FDA Approval for CAP24 Surgical Paddle Lead
Bloomington, Minnesota, USA | July 16, 2026 Saluda Medical announced that the U.S. Food and Drug Administration (FDA) has...
Saluda Medical Wins FDA Approval for CAP24 Paddle Lead
MINNEAPOLIS, Minn., July 1, 2026 Saluda Medical has achieved a major regulatory milestone with the U.S. Food and Drug...
CereVasc Completes Pivotal STRIDE Trial Enrollment for eShunt
BOSTON, June 23, 2026 CereVasc, Inc. has completed patient enrollment in its pivotal STRIDE clinical trial, marking a major...
Advertisement
